Overall, 55 % of patients treated for obesity experienced weight gain after discontinuation, compared with 44 % of those treated for T2DM
For anyone focused on long-term performance and vitality, understanding these additional benefits is key
The scale did not move
Your healthcare provider can conduct appropriate investigations, which may include thyroid function tests, hormone levels, cardiovascular assessment, or review of glycaemic control through HbA1c and glucose monitoring
Semaglutide 24 mg Once Weekly in Patients With Non-Alcoholic Steatohepatitis-Related Cirrhosis: A Randomised, Placebo-Controlled Phase 2 Trial
GLP-1 Weight Loss Program Near Dallas Serving DFW, OKC, and Houston TMRW Health is based in Dallas, Texas, and we serve patients across DFW